46 studies found for:    Friedreich's Ataxia
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Lu AA24493;   Drug: Placebo
2 Completed
Has Results
Interferon Gamma-1b in Friedreich Ataxia (FRDA)
Condition: Friedreich Ataxia
Intervention: Drug: Interferon Gamma-1b
3 Recruiting Methylprednisolone Treatment of Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Methylprednisolone
4 Completed
Has Results
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
Condition: Friedreich's Ataxia
Intervention: Drug: Idebenone
5 Completed A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: placebo;   Drug: deferiprone
6 Completed Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
7 Recruiting Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Condition: Friedreich's Ataxia
Intervention:
8 Completed Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling
Condition: Friedreich Ataxia
Intervention:
9 Active, not recruiting EPI-743 in Friedreich's Ataxia Point Mutations
Condition: Friedreich's Ataxia
Intervention: Drug: EPI-743
10 Completed A Study of Resveratrol as Treatment for Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol
11 Not yet recruiting Rosuvastatin (Crestor) in Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Rosuvastatin
12 Terminated Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: varenicline;   Drug: placebo
13 Recruiting RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
Condition: Friedreich Ataxia
Interventions: Drug: Omaveloxolone Capsules, 2.5 mg;   Drug: Omaveloxolone Capsules, 5 mg;   Drug: Omaveloxolone Capsules, 10 mg;   Drug: Placebo;   Device: Omaveloxolone Capsules, 20 mg;   Drug: Omaveloxolone Capsules, TBD mg
14 Completed Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
15 Recruiting Safety, Tolerability and Efficacy of ACTIMMUNE Dose Escalation in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Interferon γ-1b;   Drug: Placebo
16 Enrolling by invitation Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention:
17 Recruiting An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: Acetyl-L-Carnitine
18 Recruiting Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiogram (ECHO);   Procedure: Cardiac-related blood studies
19 Enrolling by invitation Safety, Tolerability and Efficacy of ACTIMMUNE Dose Escalation in Friedreich's Ataxia Study
Condition: Friedreich's Ataxia
Intervention: Drug: Interferon γ-1b
20 Completed Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept
Condition: Friedreich's Ataxia
Interventions: Drug: pioglitazone;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years